SEC Comment Letter 0000000000-25-001315 to Klotho Neurosciences, Inc. (KLTO, KLTOW) (CIK 0001907223) (KLTO)
Klotho Neurosciences, Inc. (KLTO, KLTOW) (CIK 0001907223)
Date: Feb. 6, 2025 · CIK: 0001907223 · Accession: 0000000000-25-001315
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284602
Letter
February 6, 2025 Joseph Sinkule Chief Executive Officer Klotho Neurosciences, Inc. 13576 Walnut Street, Suite A Omaha, NE 68144 Re:Klotho Neurosciences, Inc. Registration Statement on Form S-1 Filed January 30, 2025 File No. 333-284602 Dear Joseph Sinkule: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Paul Goodman, Esq.
Show Raw Text
February 6, 2025
Joseph Sinkule
Chief Executive Officer
Klotho Neurosciences, Inc.
13576 Walnut Street, Suite A
Omaha, NE 68144
Re:Klotho Neurosciences, Inc.
Registration Statement on Form S-1
Filed January 30, 2025
File No. 333-284602
Dear Joseph Sinkule:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Paul Goodman, Esq.